• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺高血压和慢性阻塞性肺病患者肥大细胞糜酶的组织学特征。

Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease.

机构信息

Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany ; These authors contributed equally to this work.

Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.

出版信息

Pulm Circ. 2014 Mar;4(1):128-36. doi: 10.1086/675642.

DOI:10.1086/675642
PMID:25006428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4070756/
Abstract

Our previous findings demonstrated an increase in pulmonary mast cells (MCs) in idiopathic pulmonary arterial hypertension (IPAH). Also, literature suggests a potential role for MCs in chronic obstructive pulmonary disease (COPD). However, a comprehensive investigation of lungs from patients is still needed. We systematically investigated the presence/expression of MCs/MC chymase in the lungs of IPAH and COPD patients by (immuno)histochemistry and subsequent quantification. We found that total and perivascular chymase-positive MCs were significantly higher in IPAH patients than in donors. In addition, chymase-positive MCs were located in proximity to regions with prominent expression of big-endothelin-1 in the pulmonary vessels of IPAH patients. Total and perivascular MCs around resistant vessels were augmented and a significant majority of them were degranulated (activated) in COPD patients. While the total chymase-positive MC count tended to increase in COPD patients, the perivascular number was significantly enhanced in all vessel sizes analyzed. Surprisingly, MC and chymase-positive MC numbers positively correlated with better lung function in COPD. Our findings suggest that activated MCs, possibly by releasing chymase, may contribute to pulmonary vascular remodeling in IPAH. Pulmonary MCs/chymase may have compartment-specific (vascular vs. airway) functions in COPD. Future studies should elucidate the mechanisms of MC accumulation and the role of MC chymase in pathologies of these severe lung diseases.

摘要

我们之前的研究结果表明,特发性肺动脉高压(IPAH)患者的肺部肥大细胞(MC)数量增加。此外,文献表明 MC 可能在慢性阻塞性肺疾病(COPD)中发挥作用。然而,仍需要对 IPAH 和 COPD 患者的肺部进行全面研究。我们通过(免疫)组织化学和随后的定量分析,系统地研究了 IPAH 和 COPD 患者肺部 MC/MC 糜酶的存在/表达。我们发现,与供体相比,IPAH 患者的总血管周围和阳性 MC 明显更高。此外,在 IPAH 患者的肺血管中,糜酶阳性 MC 位于内皮素-1 表达明显的区域附近。在 COPD 患者中,抗性血管周围的总 MC 和血管周围 MC 增加,并且它们中的大多数处于脱颗粒(激活)状态。虽然 COPD 患者的总阳性 MC 计数有增加的趋势,但所有分析的血管大小的血管周围数量均明显增加。令人惊讶的是,MC 和阳性 MC 数量与 COPD 患者的肺功能改善呈正相关。我们的研究结果表明,活化的 MC 可能通过释放糜酶来促进 IPAH 的肺血管重塑。在 COPD 中,肺 MC/糜酶可能具有特定部位(血管与气道)的功能。未来的研究应阐明 MC 积累的机制以及 MC 糜酶在这些严重肺部疾病中的作用。

相似文献

1
Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease.肺高血压和慢性阻塞性肺病患者肥大细胞糜酶的组织学特征。
Pulm Circ. 2014 Mar;4(1):128-36. doi: 10.1086/675642.
2
Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.肥大细胞在野百合碱诱导的大鼠肺动脉高压中的作用。
Respir Res. 2011 May 2;12(1):60. doi: 10.1186/1465-9921-12-60.
3
Association of mast cells with lung function in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中肥大细胞与肺功能的关联
Respir Res. 2008 Sep 10;9(1):64. doi: 10.1186/1465-9921-9-64.
4
Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease.先天性心脏病合并早期肺血管疾病患者肺组织中肥大细胞糜蛋白酶表达增加。
Am J Respir Crit Care Med. 1999 Oct;160(4):1303-8. doi: 10.1164/ajrccm.160.4.9810058.
5
Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者肺肥大细胞群体的改变。
Am J Respir Crit Care Med. 2010 Feb 1;181(3):206-17. doi: 10.1164/rccm.200906-0932OC. Epub 2009 Nov 19.
6
Mast cells in diffuse large B-cell lymphoma; their role in fibrosis.弥漫性大B细胞淋巴瘤中的肥大细胞;它们在纤维化中的作用。
Histopathology. 2006 Nov;49(5):498-505. doi: 10.1111/j.1365-2559.2006.02534.x.
7
Differential expression of mast cells in the small airways and alveolar septa of current smokers and patients with small airway disease and COPD.当前吸烟者、小气道疾病患者和慢性阻塞性肺疾病(COPD)患者的小气道和肺泡间隔中肥大细胞的差异表达。
ERJ Open Res. 2024 Mar 18;10(2). doi: 10.1183/23120541.00579-2023. eCollection 2024 Mar.
8
Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymase/mast cell protease 4-dependent mechanism.肥大细胞通过糜酶/肥大细胞蛋白酶 4 依赖性机制促进博来霉素诱导的小鼠肺炎症和损伤。
J Immunol. 2014 Feb 15;192(4):1847-54. doi: 10.4049/jimmunol.1300875. Epub 2014 Jan 22.
9
Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension.慢性阻塞性肺疾病相关性肺动脉高压和特发性肺动脉高压中的肺静脉重塑
Pulm Circ. 2017 Apr-Jun;7(2):514-521. doi: 10.1177/2045893217709762. Epub 2017 May 24.
10
Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients.肥大细胞在 COVID-19 患者严重肺部损伤发病机制中的作用。
Respir Res. 2022 Dec 21;23(1):371. doi: 10.1186/s12931-022-02284-3.

引用本文的文献

1
Immunohistochemical Analysis of Mastocyte Inflammation: A Comparative Study of COPD Associated with Tobacco Smoking and Wood Smoke Exposure.肥大细胞炎症的免疫组织化学分析:吸烟与接触木烟所致慢性阻塞性肺疾病的比较研究
Biomedicines. 2025 Jun 30;13(7):1593. doi: 10.3390/biomedicines13071593.
2
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management.肺动脉高压的免疫治疗:从发病机制到临床管理。
Int J Mol Sci. 2024 Aug 1;25(15):8427. doi: 10.3390/ijms25158427.
3
GPS2 ameliorates cigarette smoking-induced pulmonary vascular remodeling by modulating the ras-Raf-ERK axis.GPS2 通过调节 ras-Raf-ERK 轴改善吸烟诱导的肺血管重构。
Respir Res. 2024 May 16;25(1):210. doi: 10.1186/s12931-024-02831-0.
4
ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.ROCK 抑制作为肺动脉高压治疗的潜在靶点。
Cells. 2021 Jun 30;10(7):1648. doi: 10.3390/cells10071648.
5
Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.细胞因子、趋化因子与肺动脉高压中的炎症反应。
Adv Exp Med Biol. 2021;1303:275-303. doi: 10.1007/978-3-030-63046-1_15.
6
Perivascular Inflammation in Pulmonary Arterial Hypertension.肺高血压中的血管周围炎症。
Cells. 2020 Oct 22;9(11):2338. doi: 10.3390/cells9112338.
7
Endothelial Basement Membrane Components and Their Products, Matrikines: Active Drivers of Pulmonary Hypertension?内皮基底膜成分及其产物:基质细胞衍生因子,是肺动脉高压的活性驱动因素吗?
Cells. 2020 Sep 3;9(9):2029. doi: 10.3390/cells9092029.
8
is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties.在治疗肺动脉高压方面,是一种很有前途的治疗选择,因为它具有强大的抗增殖和血管舒张特性。
Medicina (Kaunas). 2020 Mar 16;56(3):131. doi: 10.3390/medicina56030131.
9
The Role of Mast Cells in IgE-Independent Lung Diseases.肥大细胞在 IgE 非依赖性肺部疾病中的作用。
Clin Rev Allergy Immunol. 2020 Jun;58(3):377-387. doi: 10.1007/s12016-020-08779-5.
10
Hypoxic mast cells accelerate the proliferation, collagen accumulation and phenotypic alteration of human lung fibroblasts.低氧致敏肥大细胞加速人肺成纤维细胞的增殖、胶原积累和表型改变。
Int J Mol Med. 2020 Jan;45(1):175-185. doi: 10.3892/ijmm.2019.4400. Epub 2019 Nov 11.

本文引用的文献

1
Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis?肥大细胞糜酶:特发性肺纤维化病理交响乐中不可或缺的乐器?
Histol Histopathol. 2013 Jun;28(6):691-9. doi: 10.14670/HH-28.691. Epub 2013 Feb 25.
2
Mast cell number, phenotype, and function in human pulmonary arterial hypertension.人肺动脉高压中的肥大细胞数量、表型和功能。
Pulm Circ. 2012 Apr-Jun;2(2):220-8. doi: 10.4103/2045-8932.97609.
3
Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease.肥大细胞浸润可区分慢性阻塞性肺疾病的组织病理学表型。
Am J Respir Crit Care Med. 2012 Aug 1;186(3):233-9. doi: 10.1164/rccm.201112-2142OC. Epub 2012 Jun 7.
4
Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者血清中基质金属蛋白酶 1、2、3、7、8、9 和金属蛋白酶组织抑制剂 1、4 的同时上调。
Respirology. 2012 Aug;17(6):1006-12. doi: 10.1111/j.1440-1843.2012.02197.x.
5
Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis.COPD 气道中的肥大细胞:与支气管扩张剂反应性和血管生成的关系。
Eur Respir J. 2012 Jun;39(6):1361-7. doi: 10.1183/09031936.00084411. Epub 2011 Oct 27.
6
Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice.诱导型一氧化氮合酶抑制逆转了香烟烟雾引起的小鼠肺气肿和肺动脉高压。
Cell. 2011 Oct 14;147(2):293-305. doi: 10.1016/j.cell.2011.08.035.
7
Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.肥大细胞在野百合碱诱导的大鼠肺动脉高压中的作用。
Respir Res. 2011 May 2;12(1):60. doi: 10.1186/1465-9921-12-60.
8
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension.在实验性肺动脉高压中,氮茚-1 的治疗效果。
Eur Respir J. 2010 Oct;36(4):808-18. doi: 10.1183/09031936.00140309. Epub 2010 Jun 7.
9
Pulmonary hypertension associated with chronic obstructive pulmonary disease.与慢性阻塞性肺疾病相关的肺动脉高压
Indian J Chest Dis Allied Sci. 2010 Jan-Mar;52(1):29-40.
10
Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters.糜酶在香烟烟雾诱导的肺动脉重构和仓鼠肺动脉高压中的作用。
Respir Res. 2010 Mar 31;11(1):36. doi: 10.1186/1465-9921-11-36.